Chemcon Speciality Chemicals Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹65 Cr +21.9% YoYSee revenue, profit and what management said. You are viewing Q4 FY24.
CS

Chemcon Speciality Chemicals Ltd

Q4 FY24Chemicals & Petrochemicals

Chemcon Speciality Chemicals Q4 FY24: Revenue ₹59.6 Cr, EBITDA margin 7.4%

Q4 FY24 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹60Cr
+12.5% QoQ
Net profit
₹3Cr
−34.7% QoQ
Margin
7.35%
−4.6 pp QoQ

Chemcon Speciality Chemicals Ltd Q4 FY24 key numbers

Revenue
FY24 Revenue: Rs 267.1 Cr, down 11.8% YoY from Rs 302.9 Cr in FY23.

As stated in Chemcon Speciality Chemicals Ltd's Q4 FY24 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.

Based on Chemcon Speciality Chemicals Ltd's Q4 FY24 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹228
Market cap₹793 Cr
P/E28.1

The short version

Q4 FY24 Revenue from Operations: Rs 59.6 Cr, down 24.6% YoY from Rs 79.1 Cr in Q4 FY23 (Page 8, 6). Q4 FY24 EBITDA: Rs. 4.4 Cr, down 68.8% YoY from Rs. 14.1 Cr in Q4 FY23.

From Chemcon Speciality Chemicals Ltd's Q4 FY24 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q4 FY24 Revenue from Operations: Rs 59.6 Cr, down 24.6% YoY from Rs 79.1 Cr in Q4 FY23 (Page 8, 6)
  • Q4 FY24 Sales Volume: 3,438 MT, slight increase from 3,231 MT in Q4 FY23 (Page 6)
  • Q4 FY24 EBITDA and PAT declined significantly YoY, reflecting softness in demand (Pages 6, 8)
  • FY24 Revenue: Rs 267.1 Cr, down 11.8% YoY from Rs 302.9 Cr in FY23 (Pages 5,7)
  • FY24 Sales Volume: 12,131 MT, up from 10,975 MT in FY23 (Page 7)

2 more points from Chemcon Speciality Chemicals Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Chemcon Speciality Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Two additional manufacturing units, P10 and P11, are planned for capacity expansion by H2FY25.
  • These new units will manufacture organic chemicals (HMDS, CMIC, Bromobenzene).
  • Installed capacity currently: Organic Chemicals at 10,800 MTPA and Inorganic Chemicals at 15,000 MTPA.
  • Expansion plants (P10 and P11) are under process as of the presentation date.
  • The aim is to add manufacturing capacity to support organic chemicals growth and import substitution.

2 more points from Chemcon Speciality Chemicals Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Chemcon Speciality Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Chemcon Speciality Chemicals Ltd said on order book & pipeline — free account, 30 seconds.

Chemcon Speciality Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Chemcon Speciality Chemicals Ltd Q4 FY24 results — key figures

Chemcon Speciality Chemicals Ltd Q4 FY24 reported results vs year-ago quarter, ₹ crore
₹ CrQ4 FY24Q3 FY24QoQ
Revenue6053+12.5%
Operating profit (EBITDA)46-30.9%
Operating margin7.35%11.97%-4.6 pp
Profit before tax46-31.4%
Net profit (PAT)34-34.7%
EPS (₹)0.791.21-34.7%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹65 Cr, net profit ₹8 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Gujarat Alkalies (Q4 FY24)

    951.17 Crores (Page 8) . Key concall takeaways from Gujarat Alkalies & Chemicals Ltd's Q4 FY24 earnings call — and how it ranks against sector peers.

  • Himadri Special (Q4 FY24)

    1,176.95 Cr, up 14.39% YoY from Rs. Key concall takeaways from Himadri Speciality Chemical Ltd's Q4 FY24 earnings call — and how it ranks against sector peers.

  • Valiant Organics (Q4 FY24)

    Revenue from Operations for Q4 FY24 (consolidated): INR 7,231 million, down from INR 10,518 million in FY23, a decline of approximately 31.2% year-on-year. Key…

  • Excel Industries (Q4 FY24)

    Q4 FY24 revenue: ₹233.5 Cr, a 3.3% increase quarter-on-quarter and a 29.5% increase year-on-year (Page 11, 9, 7, 5). Key concall takeaways from Excel…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Chemcon Speciality Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Chemcon Speciality Chemicals Ltd Q4 FY24 results?

Q4 FY24 Revenue from Operations: Rs 59.6 Cr, down 24.6% YoY from Rs 79.1 Cr in Q4 FY23 (Page 8, 6). Q4 FY24 EBITDA: Rs. 4.4 Cr, down 68.8% YoY from Rs. 14.1 Cr in Q4 FY23.

What is Chemcon Speciality Chemicals Ltd share price analysis?

Chemcon Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 28.1 with a market cap of ₹793 Cr. Investors should review the full earnings analysis for detailed insights.

Is Chemcon Speciality Chemicals Ltd planning capital expenditure?

Two additional manufacturing units, P10 and P11, are planned for capacity expansion by H2FY25.

Keep Chemcon Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.